Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: w0z who wrote (12761)	1/14/2022 9:23:59 AM
From: Kirk ©	2 Recommendations Recommended By berniel wilywilly Read Replies (1) \| Respond to of 26808

I don't blame "Big Pharma" for the loss of the control group. I blame "ethics" which means when you have a proven alternative with a superior outcome to the placebo, then you make that alternative available to the people who got the placebo. mRNA "treatments" via two jabs were proven to be 90 to 95% more effective than a placebo which carried an overall death rate of roughly 1.5%. I doubt anyone in the control group was forced to get "vaccinated" or "treated with mRNA jabs" until much later where they might lose their jobs if they don't get the jabs. See ncbi.nlm.nih.gov I see the mRNA treatments/jabs/vaccines as requiring the end of control group via these NIH guidelines: The use of placebo controls in clinical trials remains controversial. Ethical analysis and international ethical guidance permit the use of placebo controls in randomized trials when scientifically indicated in four cases: (1) when there is no proven effective treatment for the condition under study; (2) when withholding treatment poses negligible risks to participants; (3) when there are compelling methodological reasons for using placebo, and withholding treatment does not pose a risk of serious harm to participants; and, more controversially, (4) when there are compelling methodological reasons for using placebo, and the research is intended to develop interventions that can be implemented in the population from which trial participants are drawn, and the trial does not require participants to forgo treatment they would otherwise receive. The concept of methodological reasons is essential to assessing the ethics of placebo controls in these controversial last two cases. This article sets out key considerations relevant to considering whether methodological reasons for a placebo control are compelling. It would be unethical and perhaps even illegal to withhold lifesaving mRNA treatments from those who wish to get them. Just as you wish to trust luck and wishful thinking about the health of a 77 year old immune system and shouldn't be forced to get vaccinated if you continue to isolate at home, you should not force people to not get lifesaving vaccinations after they bravely signed up for a study that made the lifesaving vaccines possible. "Blaming" big Pharma for what was clearly an ethical and legal compulsion to offer the lifesaving mRNA treatments to the participants in the placebo groups is lazy thinking AND it shows how "isolated" people are clearly swayed by "fake news" and other bullshit. I hope you see this now...